Today, MAPS turns 40🥳
What began as a vision to explore the healing potential of psychedelics has grown into a global effort shaped by science, community, and care.
For four decades, this work has taken root, been carried forward through relationships, and continues to resonate today.
Roots. Relationships. Resonance.
Explore more - LINK IN BIO
MAPS Welcomes @LianaSananda and Andrew "Mo" Septimus to Board of Directors!
The appointments deepen our Board’s experience in two areas central to MAPS’ next chapter: experienced leadership and financial stewardship through periods of growth and transition.
Learn more about Liana and Mo, LINK IN BIO
42 years ago today, some of the most influential voices in psychedelic history gathered at UC Santa Barbara for the Psychedelics and Spirituality Conference, also known as Psychedelic Conference II.
Held during the height of the Reagan-era “Just Say No” campaign, the conference became a rare space for open dialogue around psychedelics, consciousness, spirituality, and research.
It was here that Sasha Shulgin announced the discovery of 2C-B, and where Terence McKenna emerged as a major public voice in psychedelics.
This ticket is a small piece of that history.
PS27 Early Bird registration is now live!
Join us while Early Bird lasts (limited availability).
Register your crew and save 20% on groups of 5+.
LINK IN BIO
We’re reflecting on the importance of maternal mental health and the need for more research and support for mothers navigating postpartum depression.
Deva Collective, a nonprofit devoted to advancing clinical research in alternative medicine for women’s health, has begun fundraising for their second study investigating ketamine-assisted psychotherapy for postpartum depression.
Learn more, LINK IN BIO
Reflecting on Mother’s Day, we’re thinking about the ways drug policy has shaped the lives of mothers, caregivers, and families for generations.
In a new piece featured by @PsychedelicsToday , MAPS Co-Executive Director Betty Aldworth examines how the War on Drugs has extended far beyond criminalization alone, impacting pregnancy, housing stability, family separation, economic opportunity, and access to care.
Read the full article, LINK IN BIO
TOMORROW, PS27 Early Bird registration opens, our most limited release at our lowest price🤑
Once Early Bird sells out, pricing moves to First Release, so get in early!!!
This year you can buy for yourself and your crew, and groups of 5+ get 20% off. Get ready.
What’s on your mind?🤔
Not saying it’s MAPS merch… just making a case for it (perhaps a lighter case👀).
Don’t forget, Members get 25% off EVERYTHING in the MAPS Store, plus access to exclusive, members-only sales through the membership portal.
Get started, and start shopping today!
LINK IN BIO
The conversation around mental health and psychedelic science is global.
@TRYPEXPO gathers for three days of talks, workshops, and immersive experiences in Berlin.
From the MAPS team, @DPhill21 will be speaking on “Culture Is the Carrier: A Framework for Scaling Psychedelic Education,” diving into how knowledge is shared and sustained as the field continues to grow.
Visit the link in our bio to secure to your tickets, and use code MAPS to get 20% off!
The conversation around psychedelics is expanding across lines that once felt fixed.
This @NYTimes piece looks at the growing bipartisan interest in psychedelic research, shaped by decades of advocacy, evolving science, and the voices of those seeking care.
Read the full article, LINK IN BIO
In today's Bulletin article, researchers @Fayzan.Rab , M.D., and Bennet Zelner, Ph.D., introduce the Psychedelics & Leadership Study – the first large-scale, systematic effort to understand how and why business leaders are turning to psychedelics, and what unfolds when they do.
Nearly all of the evidence around psychedelic use comes from clinical trials, but the leadership context in which these substances are being used is very different, and largely underexamined. The Psychedelics and Leadership study aims to examine how psychedelics are being used by leaders in real-world contexts. This matters because these experiences can affect workplace culture, employee well-being, and how psychedelics are being normalized in professional life.
Read the full piece, LINK IN BIO
